News

Research and Development (R&D) expenses: R&D expenses were $22.9 million for the first quarter of 2025, compared to $33.7 million for the first quarter of 2024. General and Administrative (G&A) ...
Indeed, from December 2024, the NHS issued guidance to stop pharmacists distributing Rybelsus (Semaglutide ... supply chains to secure access to raw materials and ensure supply continuity.
HealthDay News — For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with improved liver histologic outcomes, according to a study ...
The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...
Consumer sector companies are unlikely to pass on the benefits of reduced raw material prices to the end customers and instead use this opportunity to improve their gross profit margins ...
How Does Semaglutide Work for Weight Loss? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Ozempic. Wegovy. Rybelsus. What do these medications have in common? They all contain ...
Improvement seen in resolution of steatohepatitis without worsening of fibrosis and in fibrosis without worsening of steatohepatitis. (HealthDay News) — For patients with metabolic dysfunction ...
Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...
Findings showed a 13.6% reduction in body weight in the semaglutide 25 mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review ...
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...